Apollon Formularies (AQSE:APOL) FCF Yield % : -2.76 (As of May. 17, 2024)

View and export this data going back to . Start your Free Trial

What is Apollon Formularies FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Apollon Formularies's Trailing 12-Month Free Cash Flow is £-0.03 Mil, and Market Cap is £1.12 Mil. Therefore, Apollon Formularies's FCF Yield % for today is -2.76%.

The historical rank and industry rank for Apollon Formularies's FCF Yield % or its related term are showing as below:

AQSE:APOL' s FCF Yield % Range Over the Past 10 Years
Min: -7138.37 Med: -97.98 Max: -1.53
Current: -2.76

During the past 11 years, the highest FCF Yield % of Apollon Formularies was -1.53%. The lowest was -7138.37%. And the median was -97.98%.

AQSE:APOL's FCF Yield % is ranked worse than
60.44% of 1082 companies
in the Drug Manufacturers industry
Industry Median: -0.49 vs AQSE:APOL: -2.76

Apollon Formularies's FCF Margin % for the quarter that ended in Jun. 2023 was -64.58%.

Apollon Formularies FCF Yield % Historical Data

The historical data trend for Apollon Formularies's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollon Formularies FCF Yield % Chart

Apollon Formularies Annual Data

Trend

Jun10

Jun11

Dec12

Dec13

Dec14

Dec17

Dec18

Dec19

Dec20

Dec21

FCF Yield %

Get a 7-Day Free Trial

-2,776.03

-6.22

0.53

-15.66

Apollon Formularies Semi-Annual Data
	Jun11	Jun12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Jun23
FCF Yield %	Get a 7-Day Free Trial											4.47	-167.36	-21.82	-3.19	-4.59

Competitive Comparison of Apollon Formularies's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Apollon Formularies's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apollon Formularies's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Apollon Formularies's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Apollon Formularies's FCF Yield % falls into.

Apollon Formularies FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Apollon Formularies's FCF Yield % for the fiscal year that ended in Dec. 2021 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-3.106	/	19.8319905
	=	-15.66%

Apollon Formularies's annualized FCF Yield % for the quarter that ended in Jun. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-0.031	*	2	/	1.34958425
	=	-4.59%

Apollon Formularies FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Apollon Formularies FCF Yield % Related Terms

Thank you for viewing the detailed overview of Apollon Formularies's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollon Formularies (AQSE:APOL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Apollon Formularies PLC (AQSE:APOL) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Hope Street, Quayside House, Castletown, IMN, IM9 1AS

Website

https://www.apollon.org.uk

Apollon Formularies PLC is a London, England and Jamaican based medical cannabis pharmaceutical company specialising in research and treatment of patients with cancer and chronic pain. It is engaged in investing by seeking to acquire a direct and/or indirect interest in projects and assets in the agriculture and logistics sectors and the medicinal cannabis sector. The company focus on opportunities in Africa and Europe. It has created proprietary hybrid medical cannabis pharmaceutical strains, technology, formulations, and treatment products.